Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christa Clark

Plastic Surgery Folsom, CA Medical Doctor

NPI 1457438004 CMS profile 202360

2220 E Bidwell St, Folsom, CA 95630

Open in the dashboard

General payments

$15,792

153 records reported · program years 2019–2025

Research payments

$136,250

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christa Clark of Folsom, CA is reported in the CMS Open Payments database as having received $15,792 across 153 general payments and $136,250 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,046 30
2024 General $1,608 26
2023 General $4,821 44
2022 General $240 7
2022 Research $53,000 1
2021 General $864 12
2021 Research $75,250 1
2020 General $96 5
2020 Research $8,000 1
2019 General $6,116 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christa Clark
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Christa Clark were reported at $2,046. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Christa Clark Plastic Surgery median Middle half National median
2019 $6,116 $371 $122–$1,483 $163
2020 $96 $158 $52–$438 $114
2021 $864 $249 $87–$752 $132
2022 $240 $274 $102–$793 $149
2023 $4,821 $299 $113–$891 $160
2024 $1,608 $361 $124–$1,062 $164
2025 $2,046 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $6,571 32 payments
  2. AbbVie, Inc. $4,594 66 payments
  3. Sientra, Inc. $2,902 13 payments
  4. Mentor Worldwide LLC $641 18 payments
  5. Motiva USA, LLC $349 6 payments
  6. Tepha Inc $279 4 payments
  7. Integra LifeSciences Corporation $181 3 payments
  8. Musculoskeletal Transplant Foundation Inc. $75 1 payment
  9. Merz North America, Inc. $66 2 payments
  10. Galderma Laboratories, L.P. $53 3 payments
  11. Other $80 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Gift $5,615 4 payments
  2. Food and Beverage $4,543 130 payments
  3. Travel and Lodging $2,883 8 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,750 11 payments
Products named General payments · program years 2019–2025
  1. NATRELLE $5,735 20 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $5,374 54 payments
  3. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $2,902 13 payments
  4. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $2,171 14 payments
  5. REVOLVE $1,805 8 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $1,503 11 payments
  7. MENTOR MemoryGel Resterilizable Gel Sizer $607 17 payments
  8. BOTOX $332 19 payments
  9. Motiva Implant Matrix $329 5 payments
  10. GalaFLEX $279 4 payments
  11. Other $482 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $136,250 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

68

Median for Plastic Surgery: 39

Drug cost

$455

Median for Plastic Surgery: $219

Branded share of claims

54.4%

Median for Plastic Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Scopolamine Generic 18 $185
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 19 $128
Ondansetron Odt Ondansetron Brand 18 $90
Cephalexin Generic 13 $52

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 700 Part D prescribers listed as Plastic Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $141
$141 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record